Royalty Pharma is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in life sciences, operating at the intersection of science, medicine, and investing. With over $30 billion in announced transactions since its founding, the company has acquired 80 royalties and holds the number one position in the biopharma royalty market.
As a partner of choice in the biopharma ecosystem, Royalty Pharma offers tailored funding solutions and win-win partnerships, making it the leading partner funding innovation in life sciences with more than 60% global market share. Its unique business model provides investors with exposure to the best attributes of biopharma while minimizing industry challenges.
Generated from the website